WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Website Related Online Marketing Thursday, March 28, 2024 
Add Press Release News | News Feeds Feeds | Email This News Email


Outlook on the Acute Migraine Drugs Global Market to 2028 - Introduction of Novel Therapies in the Treatment of Migraine Presents Opportunities
Saturday, December 3, 2022

DUBLIN, Nov. 25, 2022 /PRNewswire/ -- The "Acute Migraine Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2028" report has been added to ResearchAndMarkets.com's offering.

https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The report on the global acute migraine drugs market provides qualitative and quantitative analysis for the period from 2020 to 2028. The report predicts the global acute migraine drugs market to grow with a CAGR of about 7% over the forecast period from 2022-2028.

The study on the acute migraine drugs market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2020 to 2028.

The report on the acute migraine drugs market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global acute migraine drugs market over the period of 2020 to 2028. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market, and opportunities for the new entrants in the global acute migraine drugs market over the period of 2020 to 2028. Further, IGR- Growth Matrix gave in the report brings insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

    --  Increasing demand for quality drugs
    --  Rising incidence of migraine among people

2) Restraints

    --  Side effects of migraine drugs
    --  Stringent government rules and regulations

3) Opportunities

    --  The introduction of novel therapies in the treatment of migraine will
        act as an opportunity for the acute migraine drugs market.

What does this Report Deliver?
1. Comprehensive analysis of the global as well as regional markets of the acute migraine drugs market.
2. Complete coverage of all the segments in the acute migraine drugs market to analyze the trends, and developments in the global market, and forecast market size up to 2028.
3. Comprehensive analysis of the companies operating in the global acute migraine drugs market. The company profile includes an analysis of the product portfolio, revenue, SWOT analysis, and the latest developments of the company.
4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus on to invest, consolidate, expand and/or diversify.

Key Topics Covered:

1. Preface

2. Executive Summary

3. Global Acute Migraine Drugs Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Analysis of COVID-19 impact on the Acute Migraine Drugs Market
3.4. Porter's Five Forces Analysis
3.5. IGR-Growth Matrix Analysis
3.5.1. IGR-Growth Matrix Analysis by Drug
3.5.2. IGR-Growth Matrix Analysis by Application
3.5.3. IGR-Growth Matrix Analysis by Distribution Channel
3.5.4. IGR-Growth Matrix Analysis by Region
3.6. Value Chain Analysis of Acute Migraine Drugs Market

4. Acute Migraine Drugs Market Macro Indicator Analysis

5. Global Acute Migraine Drugs Market by Drug
5.1. Abortive Medicine
5.2. Preventive Medicine

6. Global Acute Migraine Drugs Market by Application
6.1. Oral
6.2. Injectable
6.3. Nasal Sprays

7. Global Acute Migraine Drugs Market by Distribution Channel
7.1. Hospital-based Pharmacies
7.2. Retail Pharmacies
7.3. Online Pharmacies

8. Global Acute Migraine Drugs Market by Region 2022-2028

9. Company Profiles and Competitive Landscape
9.1. Competitive Landscape in the Global Acute Migraine Drugs Market
9.2. Companies Profiled
9.2.1. Endo Pharmaceuticals Inc
9.2.2. Allergan
9.2.3. Impax Laboratories
9.2.4. Glaxo Smith Kline plc
9.2.5. Astellas Pharma Inc.
9.2.6. Amgen
9.2.7. Bayer
9.2.8. AstraZeneca
9.2.9. Dr. Reddy's Laboratories
9.2.10. Zogenix

For more information about this report visit https://www.researchandmarkets.com/r/yua52i

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

View original content:https://www.prnewswire.com/news-releases/outlook-on-the-acute-migraine-drugs-global-market-to-2028---introduction-of-novel-therapies-in-the-treatment-of-migraine-presents-opportunities-301687155.html

SOURCE Research and Markets



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav JND eDiscovery Receives National Law Journal Hall of Fame Award in Two Categories | Mar 28, 2024
Nav Trip.com's Global 3.3 Promotion Sees Record Success in Asia and Europe | Mar 28, 2024
Nav Europe Fibercos and Towercos Market Dynamics Report 2024: Lessons Learned and Key Takeaways for Telcos and Infrastructure Companies | Mar 28, 2024
Nav China Non-Invasive Prenatal Testing Analysis Report 2024: Testing Volume 2018-2032 and Market Estimation Forecasts 2024-2032 with Focus on Mergers & Acquisitions, Collaborations, and Partnerships | Mar 28, 2024
Nav Global Highly Potent API (Active Pharmaceutical Ingredient) Industry Research 2023-2033: Advancements in Containment Technologies, and Increasing Investment for Manufacturing Units | Mar 28, 2024
Nav Exclusive Networks announces a major step in its growth strategy in APAC with NEXTGEN Group acquisition | Mar 28, 2024
Nav United States Self-Monitoring Blood Glucose Devices Market Research 2023-2032: SMBG Devices and CGM Systems Surge - The Shift from Traditional Blood Glucose Meters | Mar 28, 2024
Nav "Bleach: Brave Souls" Thousand-Year Blood War Zenith Summons: Reinforcements Featuring Meninas, Rangiku, and Yumichika Begins March 31 Alongside a Spring Festival Campaign | Mar 28, 2024
Nav Evolution enters Delaware through Rush Street Interactive | Mar 28, 2024
Nav IDTechEx Discusses the Sustainability of Electric Vehicle Fire Protection Materials | Mar 28, 2024
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News